The main purpose of this legislation is to impose stricter regulations on the prescription of mifepristone, a medication used for medical abortions. The law aims to ensure that patients have an in-person consultation with a healthcare provider before receiving this drug, emphasizing the importance of close monitoring for any adverse effects. Key provisions of the law require that any healthcare provider who is certified to prescribe mifepristone must conduct an in-person visit with the patient before prescribing the medication.